The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture of basic pharmaceutical products
35 jobs Number of planned job losses
Announcement Date
31 July 2017
Employment effect (start)
31 July 2017
Foreseen end date
Description
On 31 July 2017 a representative of the pharmaceutical company Lohmann confirmed the loss of 35 jobs at its site in Cuxhaven (300 employees). This is the result of a restructuring of the company’s research and development departments.
The works council has already agreed on a social compensation plan with a comparatively generous severance payment.
The company produces drugs for poultry.
Lohmann has 5,500 employees in Germany.
Sources
31 July 2017: nord24.de
2 August 2017: Cuxhavener Nachrichten (Online)
Citation
Eurofound (2017), Lohmann, Internal restructuring in Germany, factsheet number 91718, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/91718.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
